This is a preview of subscription content, log in via an institution to check access.
Reference
Endo-Tsukude C, et al. Population pharmacokinetics and adverse events of erlotinib in Japanese patients with non-small-cell lung cancer: Impact of genetic polymorphisms in metabolizing enzymes and transporters. Biological and Pharmaceutical Bulletin 41: 47-56, No. 1, Jan 2018 - Japan
Rights and permissions
About this article
Cite this article
Erlotinib. Reactions Weekly 1695, 171 (2018). https://doi.org/10.1007/s40278-018-43998-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-43998-6